← Back to Search

Diagnostic Test

Carotid PET/MRI with DOTATATE for Head and Neck Cancers

N/A

Waitlist Available

Led By Patrick Veit-Haibach, MD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up complete of enrollment, an average of two years

Awards & highlights

Study Summary

This trial is investigating whether DOTATATE-PET/MR can be used to screen and characterize patients at risk for radiation induced carotid injury.

Eligible Conditions

Head and Neck Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ complete of enrollment, an average of two years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~complete of enrollment, an average of two years

This trial's timeline: 3 weeks for screening, Varies for treatment, and complete of enrollment, an average of two years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Validity of PET/MRI with 68Ga DOTATATE of carotid arteries

Trial Design

1Treatment groups

Experimental Treatment

Group I: PET/MRI scan with 68Ga DOTATATEExperimental Treatment1 Intervention

PET/MRI scan with 68Ga DOTATATE of carotid arteries in in patients following head and neck radiation therapy

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PET/MRI of carotid arteries with 68Ga DOTATATE

2019

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,499 Total Patients Enrolled

Patrick Veit-Haibach, MDPrincipal InvestigatorUniversity Health Network, Toronto

7 Previous Clinical Trials

386 Total Patients Enrolled

Media Library

PET/MRI of carotid arteries with 68Ga DOTATATE (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04040166 — N/A

Head and Neck Cancers Research Study Groups: PET/MRI scan with 68Ga DOTATATE

Head and Neck Cancers Clinical Trial 2023: PET/MRI of carotid arteries with 68Ga DOTATATE Highlights & Side Effects. Trial Name: NCT04040166 — N/A

PET/MRI of carotid arteries with 68Ga DOTATATE (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04040166 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total count of participants in this experiment?

"Correct. Clinicaltrials.gov conveys that this scientific endeavor is presently enrolling individuals - The experiment was initially uploaded on August 22nd, 2019 and it has most recently been updated on October 31st, 2022. 60 participants are needed from 1 location."

Answered by AI

Is the enrolment process for this investigation still open to new participants?

"The information present at clinicaltrials.gov indicates that this trial is still recruiting prospective patients. It was first announced on August 22nd of 2019, and the most recent update took place in October 31st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy

2019. "Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04040166.